December 1, 2009 (FinancialWire) — CompuMed, Inc. (OTCBB: CMPD), a medical informatics and software company, said its OsteoGram(R) bone density software will be showcased at the nation’s leading medical conference, the Radiological Society of North America, November 29 – December 3, 2009, at the McCormick Place Convention Center in Chicago.

The OsteoGram is the only FDA-cleared system that enables film-based or digital x-ray devices to perform bone density tests as an indicator of osteoporosis. By utilizing widely available standard x-ray equipment, the OsteoGram has the potential to make bone density tests available and affordable to patients and physicians everywhere.

The OsteoGram will be demonstrated throughout the conference by TI-BA Enterprises (Booth #3006), one of the nation’s largest distributors of Kodak/Carestream digital and X-ray film-based products.

The OsteoGram is also being offered at RSNA by FUJIFILM Medical Systems (Booth #6238), Swissray International (Booth# 7332) and other OEM partners as part of their digital X-ray systems.

According to the National Osteoporosis Foundation, Osteoporosis strikes one in two women and one in four men in the United States. Yet more than 70 percent of osteoporosis in the U.S. goes undiagnosed and untreated, despite the availability of safe and effective treatments that can prevent or dramatically reduce the consequences of osteoporosis.

Using CompuMed’s patented OsteoGram system, healthcare providers can detect osteoporosis at the point of care in two minutes while being connected to the most accurate and up-to-date clinical and reimbursement information available in the osteoporosis testing market TODAY. Additionally, CompuMed’s OsteoCare Clinical Network supports physicians in communicating the results and benefits of bone density testing to patients and referring physicians and accessing support services offered by professional organizations, government entities and pharmaceutical firms.

According to the National Committee for Quality Assurance, only 20 percent of women 67 years of age or older hospitalized for hip fractures currently receive either a bone density test or a prescription for an anti-osteoporosis medication in the six months after hip fracture. NCQA, through its Health Employers Data Information Set (HEDIS) initiative, is seeking to bring this figure closer to 100 percent. As part of its Physician Quality Reporting Initiative, Medicare will offer financial incentives in 2010 to healthcare providers who make progress towards this and other disease prevention goals.

Previous bone density testing solutions suffer from three major shortcomings. First, the technology is too costly and cumbersome for healthcare providers and their patients. Second, providers face an ever-changing maze of reimbursement and regulatory challenges, which have been beyond the ability of most private practices and even many larger healthcare organizations to navigate in a cost-effective way. Third, osteoporosis testing results are too difficult for many physicians and most patients to understand.

CompuMed’s OsteoGram system provides physicians, hospitals and managed care organizations with the technology platform and support needed to reach these important goals. By working to overcome the key obstacles that have limited the utility and availability of previous bone density testing solutions, CompuMed is well positioned to play an important role in the fight against osteoporosis, one of TODAY’s most prevalent and yet preventable diseases.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.